Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tectonic family member 1 (TCTN1) is a transmembrane and secreted protein that is part of the tectonic family, involved in the formation and function of primary cilia—cellular organelles essential for developmental signaling pathways, including the Hedgehog pathway[1][2]. TCTN1 has been implicated in regulating ciliary membrane composition and serves critical roles in vertebrate embryogenesis, particularly in neural tube patterning and organogenesis[1]. Dysregulation and overexpression of TCTN1 are associated with several cancers (including glioblastoma and oral squamous cell carcinoma), where it promotes tumor cell proliferation, migration, and invasion[1][2]. It is also involved in human genetic disorders known as ciliopathies (e.g., Joubert and Varadi syndromes), and may act as a novel oncogenic driver and a potential therapeutic target in select tumors[1][2]. Currently, no clinically approved drugs specifically target TCTN1, but its expression may have clinical value as a biomarker for tumor aggressiveness and disease progression[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tectonic family member 1 (TCTN1).